An Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of JNJ-39439335 Capsule Formulations Administered as a Single Oral Dose in Healthy Male Adult Subjects.

Trial Profile

An Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of JNJ-39439335 Capsule Formulations Administered as a Single Oral Dose in Healthy Male Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2013

At a glance

  • Drugs Mavatrep (Primary)
  • Indications Musculoskeletal pain; Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jun 2012 Actual patient numbers amended from 32 to 43 as reported by ClinicalTrials.gov.
    • 03 May 2012 Actual patients number is 32 as reported by ClinicalTrials.gov.
    • 03 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top